From GE Healthcare;
'EXCITE technology has the potential to open the door to new imaging techniques and clinical applications, leaping beyond conventional two and three-dimensional MRI to true 4D imaging that will improve the diagnosis of disease throughout the human body from head to foot.' Robert R. Edelman, M.D., Professor of Radiology at Northwestern University Medical School and Chairman, Department of Radiology, at Evanston Northwestern Healthcare.

From GE Healthcare;
three dedicated MRI systems - a neuro imager, a cardiovascular system, and a whole body scanner - all in one system.

From Philips Medical Systems;
the Intera 3 T high field system, the first with a compact magnet, which is built on the same platform as the 1.5 T, is targeted to high-end neurological, orthopedic and cardiovascular imaging applications with maximum patient comfort and acceptance without compromising image quality and clinical performance. Useable for clinical routine and research. The Intera systems offer diffusion tensor imaging (DTI) fiber tracking that measures movement of water in the brain and can therefore detect areas of the brain where normal movement of water is disrupted.

From Siemens Medical Systems;
the MAGNETOM Concerto is easy to site and has low life cycle costs due to the permanent magnet. The powerful gradient system with 20 mT/m and a slew rate of 40 T/m/s permits high field applications on a low field open MRI system. The three-sided fully open magnet results in maximum acceptance of claustrophobic or anxious patients and patient access.

Contrast enhanced MRI is a commonly used procedure in magnetic resonance imaging. The need to more accurately characterize different types of lesions and to detect all malignant lesions is the main reason for the use of intravenous contrast agents.
Some methods are available to improve the contrast of different tissues. The focus of dynamic contrast enhanced MRI (DCE-MRI) is on contrast kinetics with demands for spatial resolution dependent on the application. DCE-MR imaging is used for diagnosis of cancer (see also liver imaging, abdominal imaging, breast MRI, dynamic scanning) as well as for diagnosis of cardiac infarction (see perfusion imaging, cardiac MRI). Quantitative DCE-MRI requires special data acquisition techniques and analysis software.
Contrast enhanced magnetic resonance angiography (CE-MRA) allows the visualization of vessels and the temporal resolution provides a separation of arteries and veins. These methods share the need for acquisition methods with high temporal and spatial resolution.
Double contrast administration (combined contrast enhanced (CCE) MRI) uses two contrast agents with complementary mechanisms e.g., superparamagnetic iron oxide to darken the background liver and gadolinium to brighten the vessels. A variety of different categories of contrast agents are currently available for clinical use.
Reasons for the use of contrast agents in MRI scans are:
Common Indications:
Brain MRI : Preoperative/pretreatment evaluation and postoperative evaluation of brain tumor therapy, CNS infections, noninfectious inflammatory disease and meningeal disease.
Spine MRI : Infection/inflammatory disease, primary tumors, drop metastases, initial evaluation of syrinx, postoperative evaluation of the lumbar spine: disk vs. scar.
Breast MRI : Detection of breast cancer in case of dense breasts, implants, malignant lymph nodes, or scarring after treatment for breast cancer, diagnosis of a suspicious breast lesion in order to avoid biopsy.

For Ultrasound Imaging (USI) see Contrast Enhanced Ultrasound at Medical-Ultrasound-Imaging.com. See also Blood Pool Agents, Myocardial Late Enhancement, Cardiovascular Imaging, Contrast Enhanced MR Venography, Contrast Resolution, Dynamic Scanning, Lung Imaging, Hepatobiliary Contrast Agents, Contrast Medium and MRI Guided Biopsy.